Log inSign up
Pharma-Marketing.comPharma-Marketing.com
  • Industry
  • Digital Health & AI
  • Channels
  • People
  • Agencies
  • Glossary
Log inSign up
  • Terms of Service
  • Privacy Policy
  • Cookie settings
  • Imprint
Pharma-Marketing.com

Copyright 2025 Pharma-Marketing.com.
All rights reserved.

We use AI tools in the creation of certain content.

Pharma Marketing

Data-privacy settings

We use cookies to improve our website and services. They help us understand how visitors use our website. Some cookies are required for the website to function. These are marked as “essential” in the details.

AcceptEssential cookie
NameData-privacy settings
ProviderPharma-Marketing.com
PurposeStores these privacy settings in your browser.
Privacy policyPrivacy policy
Cookiespm_data_privacy
Cookie expiration180 days
Accept
NameGoogle Analytics
ProviderGoogle LLC
PurposeCookies by Google are used for website analytics. Generates statistical data on how the visitor uses the website.
Privacy policyPrivacy policy
Cookies_ga, _gat, _gid
Cookie expiration2 Years
Accept
NameGoogle Ads
ProviderGoogle LLC
PurposeCookies by Google Ads are used for advertising and targeting purpose.
Privacy policyPrivacy policy
Cookies__gsas, __gpi, __gpi_optout, NID, DSID, test_cookie, id, __gads
Cookie expiration2 Years
Accept
NameFacebook
ProviderFacebook Inc.
PurposeCookies by Facebook are used for advertising and marketing activities. Generates statistical data on how the visitor uses the website.
Privacy policyPrivacy policy
Cookies_fbp, fr
Cookie expiration2 Years
Accept
NameMicrosoft Clarity
ProviderMicrosoft Corporation
PurposeCookies by Microsoft Clarity are used for website analytics, heatmaps, and session recordings. They help us understand how visitors interact with our website so we can improve usability and performance.
Privacy policyPrivacy policy
Cookies_clck, _clsk, CLID, ANONCHK, MR, MUID, SM
Cookie expirationUp to 1 Year
Image: STADA Arzneimittel AG

Friday, December 5, 2025

STADA strengthens global legal function: Ole Wendler Pedersen becomes new Executive Vice President Legal and General Counsel

STADA announces an important leadership change: Effective 1 December 2025, the company has appointed Ole Wendler Pedersen as Executive Vice President Legal and General Counsel. He succeeds Christoph Dengler, who is leaving STADA after nearly 14 years to pursue new professional opportunities outside the Group.

The Danish national will be based at the company’s headquarters in Bad Vilbel near Frankfurt and will report directly to CEO Peter Goldschmidt as a member of the STADA Executive Committee. Pedersen brings more than 20 years of international legal expertise, most recently serving as Group General Counsel at Lundbeck, a global, publicly listed pharmaceutical company developing and marketing innovative therapies for brain diseases. Prior to Lundbeck, he held several leadership roles at Novo Nordisk across different regions, including Regional General Counsel and Vice President of Legal, Compliance & Quality for Novo Nordisk Europe.

CEO Goldschmidt highlights the strategic value of the appointment: “Ole brings a strategic and operational business focus that spans R&D, manufacturing, commercial functions, as well as the oversight of complex merger and acquisition processes.” His extensive experience in building organizations and driving transformative leadership across therapeutic areas and geographies is expected to further strengthen Legal as a core business function within STADA.

Pedersen describes his decision to join STADA at this pivotal time as highly intentional. He emphasized his enthusiasm for leading the global legal department as an integral part of the company, enabling growth, fostering innovation, and supporting teams worldwide in delivering trusted healthcare solutions.

Goldschmidt also expressed his appreciation for the contributions of Christoph Dengler, who led the Legal function – including Compliance, IP and Risk Management – with dedication and creative thinking. Dengler played a critical role in navigating the legal complexities of the 2017 acquisition by Bain Capital and Cinven and was equally instrumental in preparing for the transition to CapVest, expected to conclude an important phase in STADA’s strategic development.

Pedersen’s appointment marks a significant step in further reinforcing STADA’s global governance and legal structures.

Advertisement

Only a few physicians log in to your website?

Advertisement

A login that sets a new standard for authenticating HCPs and equips your marketing team with everything they need to successfully promote Rx-products. Learn more on DocID.pro


Stay up to date!

Subscribe to our free Pharma-Marketing-Newsletter.


A Partner For Successful Marketing in Pharma & Healthcare

Advertisement

8awake, the specialized agency for pharma and healthcare marketing, supports you with the successful development and execution of winning campaign activities in healthcare.

Leading providers in pharma and healthcare marketing

Sponsored
  • MINTT Digital
  • 8awake
  • MINTT Digital

  • 8awake

    The leading Healthcare & Pharma-Marketing-Agency

Looking for a new partner in pharma and healthcare marketing?

Visit our agency finder